Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease

医学 中医药 临床试验 体内 内科学 传统医学 药理学 病理 替代医学 生物 生物技术
作者
Feipeng Xu,Hua Zhang,Jiamei Chen,Junyi Zhan,Ping Liu,Wei Liu,Shenglan Qi,Yongping Mu
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:321: 117514-117514 被引量:7
标识
DOI:10.1016/j.jep.2023.117514
摘要

Chronic liver diseases mainly include chronic viral liver disease, metabolic liver disease, cholestatic liver disease (CLD), autoimmune liver disease, and liver fibrosis or cirrhosis. Notably, the compound formulas of traditional Chinese medicine (TCM) is effective for chronic liver diseases in clinical trials and basic research in vivo, which provide evidence of chronic liver disease treatment with integrated TCM and traditional Western medicine. This paper aims to provide a comprehensive review of the compound formulas of TCM for treating different chronic liver diseases to elucidate the composition, main curative effects, and mechanisms of these formulas and research methods. Different keywords related to chronic liver diseases and keywords related to the compound formulas of TCM were used to search the literature. PubMed, Scopus, Web of Science, and CNKI were searched to screen out original articles about the compound formulas of TCM related to the treatment of chronic liver diseases, mainly including clinical trials and basic in vivo research related to Chinese patent drugs, classic prescriptions, proven prescriptions, and hospital preparations. We excluded review articles, meta-analysis articles, in vitro experiments, articles about TCM monomers, articles about single-medicine extracts, and articles with incomplete or uncertain description of prescription composition. Plant names were checked with MPNS (http://mpns.kew.org). In this review, the clinical efficacy and mechanism of compound formulas of TCM were summarized for the treatment of chronic viral hepatitis, nonalcoholic fatty liver disease, CLD, and liver fibrosis or cirrhosis developed from these diseases and other chronic liver diseases. For each clinical trial and basic research in vivo, this review provides a detailed record of the specific composition of the compound formulas of TCM, type of clinical research, modeling method of animal experiments, grouping methods, medication administration, main efficacy, and mechanisms. The general development process of chronic liver disease can be summarized as chronic hepatitis, liver fibrosis or cirrhosis, and hepatocellular carcinoma. The compound formulas of TCM have some applications in these stages of chronic liver diseases. Owing to the continuous progress of medical technology, the benefits of the compound formulas of TCM in the treatment of chronic liver diseases are constantly changing and developing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Akim应助段玉杰采纳,获得10
1秒前
Lucas应助Frankenstein采纳,获得10
2秒前
我是老大应助贝加尔湖畔采纳,获得30
2秒前
小蘑菇应助早早采纳,获得10
2秒前
平常雨泽发布了新的文献求助10
3秒前
烟花应助飘逸鑫采纳,获得10
4秒前
别骂小喷菇完成签到,获得积分10
4秒前
4秒前
科研通AI5应助水门采纳,获得10
5秒前
Lucas应助TANG采纳,获得10
6秒前
思源应助猪猪hero采纳,获得10
6秒前
无限的灵安完成签到,获得积分10
6秒前
Gsyin完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
333水完成签到 ,获得积分10
8秒前
知性的奎发布了新的文献求助10
8秒前
9秒前
Sunrising发布了新的文献求助200
9秒前
Orange应助YYMM采纳,获得10
10秒前
cdercder应助victory_liu采纳,获得10
10秒前
11秒前
12秒前
12秒前
13秒前
13秒前
Frankenstein完成签到,获得积分10
13秒前
14秒前
贝加尔湖畔完成签到,获得积分10
14秒前
一晃儿完成签到,获得积分10
15秒前
pgg147852完成签到,获得积分10
15秒前
15秒前
顺利卷卷发布了新的文献求助10
15秒前
16秒前
所所应助song采纳,获得10
17秒前
爱与感谢发布了新的文献求助10
17秒前
17秒前
吃饭了没发布了新的文献求助10
18秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3814903
求助须知:如何正确求助?哪些是违规求助? 3358983
关于积分的说明 10399256
捐赠科研通 3076557
什么是DOI,文献DOI怎么找? 1689851
邀请新用户注册赠送积分活动 813339
科研通“疑难数据库(出版商)”最低求助积分说明 767608